Generating AI analysis...
AI Earnings Analysis
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Revenue | $2.29B | $2.46B | -7.00% |
Cost of Revenue | $542.2M | $662.8M | -18.20% |
Net Income | $393.4M | $387.9M | +1.42% |
EPS (Basic) | $2.71 | $2.69 | +0.74% |
EPS (Diluted) | $2.70 | $2.67 | +1.12% |
SG&A Expense | $581.5M | $605M | -3.88% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Total Assets | $26.57B | $24.6B | +8.01% |
Current Assets | $6.76B | $9.76B | -30.79% |
Total Liabilities | $11.35B | $10.81B | +5.02% |
Current Liabilities | $3.22B | $3.01B | +6.90% |
Long-Term Debt | $6.29B | $6.28B | +0.12% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Operating Cash Flow | $553.2M | $455.3M | +21.50% |
Investing Cash Flow | $-66M | $-953M | +93.07% |
Financing Cash Flow | $-439.6M | $-43.4M | -912.90% |
D&A | $147.5M | $112.3M | +31.34% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Net Margin | 17.2% | — | — |
ROA | 1.5% | — | — |
Current Ratio | $2.096 | — | — |
Other companies in Biotechnology